COLORADO STATE UNIVERSITY and COLORADO STATE VENTURES: Appointed pharmaceutical leader Dr. Terry Opgenorth as the chief operating officer for NeoTrex and MicroRx, the university’s new infectious-disease and cancer enterprises.
linkCOLORADO STATE UNIVERSITY and COLORADO STATE VENTURES: Appointed pharmaceutical leader Dr. Terry Opgenorth as the chief operating officer for NeoTrex and MicroRx, the university’s new infectious-disease and cancer enterprises.
link